Photochemotherapeutic strategy against Acanthamoeba infections

Area of Science:

• Medicinal Chemistry
• Parasitology
• Photodynamic Therapy

Background:

• Acanthamoeba infections, including keratitis and encephalitis, pose significant health risks with current treatments often leading to recurrence.
• Photochemotherapy shows potential but lacks selective targeting of Acanthamoeba.
• Mannose-binding proteins on Acanthamoeba surface present a target for selective drug delivery.

Purpose of the Study:

• To synthesize a mannose-conjugated porphyrin photosensitizer.
• To evaluate the in vitro efficacy of this compound for targeted Acanthamoeba photodynamic therapy.

Main Methods:

• Synthesis of mannose-conjugated porphyrin via tetraphenylporphyrin, mono-nitrophenylporphyrin, and mono-aminophenylporphyrin intermediates.
• Spectroscopic confirmation of synthesis and light absorption properties (425-475 nm).
• In vitro testing on Acanthamoeba, including exposure to the compound followed by light activation.

Main Results:

• Mannose-conjugated porphyrin demonstrated potent trophicidal effects and inhibited excystation in Acanthamoeba.
• The compound significantly reduced Acanthamoeba-mediated host cell cytotoxicity from 97% to 4.9%.
• Porphyrin or mannose alone showed no significant antiamoebic effect, highlighting the conjugate's specificity.

Conclusions:

• Mannose-conjugated porphyrin is effective for targeted photodynamic therapy against Acanthamoeba.
• This approach offers a promising strategy for treating Acanthamoeba infections.
• The study provides a model for developing therapeutic interventions against other eukaryotic infections.